Aspirin and EPA Show Promise for Reducing the Numbers of Precancerous Colon Polyps

Inflammasomes and colon cancer

Both aspirin and omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA), reduced the number of precancerous colon polyps in patients found to be at high risk of developing bowel cancer, according to new research published in the journal Lancet. This study, called the seAFOod Trial, is the result of a multidisciplinaryRead

Could Cannabidiol Be the Answer to Treatment-resistant Epilepsy & Lennox-Gastaut Syndrome?

The level of frustration and hopelessness is high among one-third of epilepsy cases that are resistant to medication. A just-released study in Lancet, outlines how a pharmaceutical formulation of cannabidiol (20 mg/kg daily), alongside other anti-epilepsy treatments, reduced the number of drop seizures – seizures which involve sudden falls due

Read more

Global PURE Study on High-Carb, Low-Fat Diets Points to Poor Outcomes

Cardiovascular Disease Risk

The long awaited PURE study is out and the results will put the supporters of diets low in all types of fats into a carbohydrate-fueled tailspin. According to the large cohort Prospective Urban Rural Epidemiology (PURE) study, higher fat diets that include both saturated and unsaturated fats are associated withRead

Integrative Psychiatry Effective but Overlooked for Cancer Patients

Nearly three-quarters of cancer patients who have major depression are not currently receiving treatment for depression, and that a new integrated treatment programme is strikingly more effective at reducing depression and improving quality of life than current care, according to three papers published in The Lancet Psychiatry, The Lancet, and The Lancet Oncology. Lead author Professor Michael Sharpe from the University of Oxford in the UK, says “The huge benefit that DCPC delivers for patients with cancer and depression shows what we can achieve for patients if we take as much care with the treatment of their depression as we do with the treatment of their cancer.” By M Sharpe, et al., published in the Lancet and Lancet Oncology, Aug. 2014.